World News Releases

  • Today May 31
CMI Energy awarded a contract for the Mohammed bin Rashid al Maktoum solar park in Dubai
December 04, 2018 15:10
A CMI Solar Receiver Will Equip the World's Tallest Solar Tower in Dubai
After its commercial success in China for the design and supply of a thermal solar receiver at Haixi, CMI has just been awarded a new contract for engineering and supplying a receiver for the Mohammed
December 04, 2018 11:55
Tiziana Completes Patient Enrollment in a Phase 2a Trial to Evaluate Tolerability and Anti-Tumor Activity of Milciclib in Hepatocellular Carcinoma (HCC)
Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces
December 04, 2018 11:40
Takeda to Present Positive Data from TOURMALINE-MM3, First Pivotal Phase 3 Placebo Controlled Trial Evaluating Proteasome Inhibitor Treatment in Maintenance Setting
Takeda Pharmaceutical Company Limited (TSE:4502) today announced that data from the Phase 3 randomized, TOURMALINE-MM3 study evaluating the effect of single-agent oral NINLARO™ (ixazomib) as a mainten
December 04, 2018 10:35
Celgene Corporation Announces Initial Clinical Data from Ongoing Phase 1/2 Evolve Trial with Anti-BCMA CAR T Therapy JCARH125 in Relapsed/Refractory Multiple Myeloma at ASH 2018
Celgene Corporation (NASDAQ:CELG) today announced initial safety data from its ongoing proof-of-concept trial of JCARH125 in patients with relapsed/refractory multiple myeloma. JCARH125 is an investig
December 04, 2018 09:05
Alteogen and Lynkogen Expand Agreement to Include Additional Proprietary Fusion Proteins Targeting NASH
Alteogen Inc. (196170.KQ) and Lynkogen Inc. today announced that they have expanded the scope of their exclusive option agreement. In addition to the originally announced GLP-1 mimetic fusion proteins
December 03, 2018 20:00
Vitruvias Therapeutics Inc., and Sunny Pharmtech Inc., Announce the FDA Approval of Generic Aminocaproic Acid 500 mg and 1000 mg Tablets
Sunny Pharmtech, Inc., a Taiwan-based API and finished-dose drug development company, and Vitruvius Therapeutics Inc., an Auburn, Alabama-based generic drug company announced today that their Abbrevia
December 03, 2018 19:50
FPT Television Selects Telaria to Manage and Monetize Connected TV Inventory Programmatically
FPT Television, the leading pioneer of IPTV services in Vietnam, today announced it has selected Telaria (NYSE:TLRA), the complete software platform to manage video advertising for premium publishers,
December 03, 2018 19:45
Char Popp Joins PSB as Senior Vice President and Global Head of Qualitative Research
PSB, a global research-based consultancy, announced today that Char Popp has joined the firm as Senior Vice President and Global Head of Qualitative Research to oversee the growth and development of t
December 03, 2018 19:35
ACM Global Laboratories Appoints Brian Wright as President
Rochester Regional Health (RRH), a $2.2 USD billion integrated health care delivery system with more than 17,000 employees, has announced that its wholly-owned subsidiary, ACM Global Laboratories, has
December 03, 2018 19:25
An Unprecedented Initiative Supported By the United Arab Emirates
“A common vision for Arab Digital Economy” is the bold plan driven by the Council of Arab Economic Unity (CAEU) at the League of Arab States to boost political and social stability in the Arab World t
December 03, 2018 18:30
AerSale Acquires Avborne to Expand MRO Capabilities
AerSale®, a global supplier of mid-life aircraft, engines, used serviceable material, and maintenance, repair, and overhaul (MRO) services, today announced it has acquired aircraft component repair sp
December 03, 2018 17:35
The Fukushima I Want to Show the World Photo Contest 2018; Fukushima International Association's Announcement of the Prize-Winning Photos
Fukushima International Association recently held a photo contest for foreign residents living in Fukushima. We received many photos and messages from foreign residents who wanted to demonstrate Fukus
December 03, 2018 17:15
Andersen Global Announces Expansion of Global Board
Andersen Global announced today the expansion of its Global Board of Directors with two new board members: Seyi Bickersteth, Partner at Andersen Tax in Nigeria, and Lena Hamdi, Partner at Andersen Tax
December 03, 2018 17:10
Sigma Systems Newly Included within the Gartner November 2018 Magic Quadrant for Configure, Price and Quote Application Suites
Sigma Systems, the global leader in catalog-driven software, today announced that Sigma Systems has been recognized and placed for the first time within the Gartner November 2018 Magic Quadrant for Co
December 03, 2018 16:55
GSMA Announces First Details for MWC19 Shanghai
The GSMA today announced the first details of MWC19 Shanghai (formerly Mobile World Congress Shanghai), including participating companies, as well as a range of programmes and activities taking place
December 03, 2018 15:45
European Commission Approves ALUNBRIG® (brigatinib) for ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib, Advancing Treatment Paradigm in Europe
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Commission (EC) granted marketing authorization for ALUNBRIG (brigatinib) as a monotherapy for the treatment of adul
December 03, 2018 14:25
Celgene Corporation Announces Results of AUGMENT Evaluating REVLIMID® In Combination with Rituximab (R2) In Patients with Relapsed/Refractory Indolent Lymphoma At ASH 2018
Celgene Corporation (NASDAQ: CELG) today announced results of the phase 3 AUGMENT study, which showed that REVLIMID® (lenalidomide) in combination with rituximab (R2) demonstrated superior progression
December 03, 2018 13:55
Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 MEDALIST Trial Evaluating Luspatercept in Patients with Myelodysplastic Syndromes at the ASH 2018 Plenary Session
Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from the pivotal, phase 3 MEDALIST trial evaluating the efficacy and safety of investigational luspa
December 03, 2018 13:05
Celgene Corporation Announces Initial Phase 1/2 Liso-cel Data in Patients with Relapsed/Refractory CLL, Including Those with High-Risk Disease, Previously Treated with Ibrutinib, at ASH 2018
Celgene Corporation (NASDAQ: CELG) today announced initial data from the dose-escalation part of an ongoing, open-label multicenter phase 1/2 study of investigational lisocabtagene maraleucel (liso-ce
December 03, 2018 11:55
Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 BELIEVE Trial Evaluating Luspatercept in Adult Patients with Beta-Thalassemia at ASH 2018
Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from a pivotal, phase 3 trial (BELIEVE) evaluating the safety and efficacy of luspatercept for the t
December 03, 2018 09:10
Marriott Announces Starwood Guest Reservation Database Security Incident
Marriott has taken measures to investigate and address a data security incident involving the Starwood guest reservation database. On November 19, 2018, the investigation determined that there was una
December 01, 2018 22:50
Ludos Protocol Continues High Profile Marketing Campaign with Times Square Advertisements
Ludos Protocol, the outstanding blockchain infrastructure to solve latency problems in gaming industry, secured coveted spots on a highly-visible Times Square’s digital billboard as part of its compre
December 01, 2018 22:15
Brightline Initiative Study Identifies Crisis Mode Learnings that Create Stronger Strategy Implementation Capabilities
In partnership with Quartz Insights, Brightline™ Initiative today announces the release of research report “Learning From Crisis Mode - Implications for Better Strategy Implementation”. The report aim
December 01, 2018 22:00
Chinese Youth Wallets Are the Target: A US$9 Trillion Digital Youthquake
The battle is on for the hearts, minds (and wallets) of Chinese Millennials. According to Futurologist Rocky Scopelliti who has just released a new book Youthquake 4.0 - A Whole Generation and The New
December 01, 2018 21:45
FedEx Institute of Technology Partners with XYO Network to Build Out Location-Based Technology Capabilities
XYO Network, the technology bringing blockchain to the real world, today announced it will partner with FedEx Institute of Technology to jointly explore benefits and opportunities based on XYO’s work
25 per page50 per page75 per page100 per page